Fulgent Genetics, Inc. Common Stock (FLGT) Stock Price

FLGTStock

$19.61−10.98%52W

Market Cap$539.57M

P/E—

PEG Ratio—

Div yield—

Beta0.98

FLGT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-27.00%

Price vs S&P 500 (4W)9.82%

VGM Score40.04

P/CF (Annual)21.90x

Book Value / Share (Quarterly)$36.40

P/TBV (Annual)0.83x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-19.52%

Cash Flow / Share (Quarterly)$-3.77

Price vs S&P 500 (YTD)-38.17%

Gross Margin (TTM)35.58%

Net Profit Margin (TTM)-26.05%

EPS (TTM)$-2.83

10-Day Avg Trading Volume0.22M

EPS Excl Extra (TTM)$-2.83

Revenue Growth (5Y)-5.21%

EPS (Annual)$-1.97

ROI (Annual)-5.43%

Gross Margin (Annual)40.56%

Net Profit Margin (5Y Avg)-3.51%

Cash / Share (Quarterly)$9.34

Revenue Growth QoQ (YoY)4.38%

ROA (Last FY)-4.99%

Revenue Growth TTM (YoY)6.83%

EBITD / Share (TTM)$-3.77

ROE (5Y Avg)6.23%

Operating Margin (TTM)-37.75%

Cash Flow / Share (Annual)$-4.00

P/B Ratio0.51x

P/B Ratio (Quarterly)0.58x

Net Income / Employee (Annual)$-46,000

EV / Revenue (TTM)1.52x

Net Interest Coverage (TTM)0.17x

ROA (TTM)-7.22%

EV / EBITDA (TTM)2.65x

EPS Incl Extra (Annual)$-1.97

Current Ratio (Annual)6.48x

Quick Ratio (Quarterly)4.72x

3-Month Avg Trading Volume0.39M

52-Week Price Return-10.98%

EV / Free Cash Flow (Annual)2.11x

Revenue / Employee (TTM)$246,300

Tangible BV / Share (Quarterly)$30.98

P/S Ratio (Annual)1.59x

Asset Turnover (Annual)0.27x

52-Week High$31.04

Operating Margin (5Y Avg)-6.32%

EPS Excl Extra (Annual)$-1.97

CapEx CAGR (5Y)-8.45%

Tangible BV CAGR (5Y)78.18%

26-Week Price Return-15.07%

Quick Ratio (Annual)5.16x

13-Week Price Return7.51%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)6.34x

Enterprise Value$491.05M

Revenue / Share Growth (5Y)-9.74%

Asset Turnover (TTM)0.28x

Book Value / Share Growth (5Y)12.12%

Revenue / Employee (Annual)$245,400

Pretax Margin (Annual)-21.70%

Cash / Share (Annual)$10.81

3-Month Return Std Dev52.57%

Gross Margin (5Y Avg)50.41%

Net Income / Employee (TTM)$-64,200

ROE (Last FY)-5.44%

EPS Basic Excl Extra (Annual)$-1.97

P/FCF (TTM)73.84x

Receivables Turnover (TTM)4.56x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-2.83

Receivables Turnover (Annual)4.20x

ROI (TTM)-7.85%

P/S Ratio (TTM)1.58x

Pretax Margin (5Y Avg)-0.45%

Revenue / Share (Annual)$10.48

Tangible BV / Share (Annual)$31.49

Forward P/E88.46x

Price vs S&P 500 (52W)-29.54%

Year-to-Date Return-25.35%

5-Day Price Return0.82%

EPS Normalized (Annual)$-1.97

ROA (5Y Avg)5.59%

Net Profit Margin (Annual)-18.75%

Month-to-Date Return18.49%

Cash Flow / Share (TTM)$-1.20

EBITD / Share (Annual)$-3.02

Operating Margin (Annual)-31.31%

LT Debt / Equity (Annual)0.00x

P/CF (TTM)302.87x

ROI (5Y Avg)6.03%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-2.83

P/TBV (Quarterly)0.68x

P/B Ratio (Annual)0.73x

Pretax Margin (TTM)-28.54%

Book Value / Share (Annual)$35.78

Price vs S&P 500 (13W)5.56%

Beta0.98x

P/FCF (Annual)107.03x

Revenue / Share (TTM)$11.57

ROE (TTM)-7.87%

52-Week Low$13.46

vGradeC

gGradeD

mGradeC

vgmGradeC

FLGT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Jul 30, 2026	-$0.44	-$0.58	-32.18%(-$0.14)
Q1 2026	May 1, 2026	-$0.35	-$0.36	-3.40%(-$0.01)
Q4 2025	Feb 27, 2026	$0.03	$0.16	+436.37%(+$0.13)
Q3 2025	Nov 7, 2025	-$0.22	$0.14	+162.46%(+$0.36)
Q2 2025	Aug 1, 2025	-$0.18	$0.07	+137.87%(+$0.25)

FLGT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

2.17

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.61
NTRANatera, Inc. Common Stock	F	A	B	$326.26
LHLabcorp Holdings Inc.	C	D	B	$335.11
DGXQuest Diagnostics Inc.	C	D	B	$242.76
GHGuardant Health, Inc. Common Stock	F	A	B	$161.50
CAICaris Life Sciences, Inc. Common Stock	F	A	C	$25.63
RDNTRadNet, Inc. Common Stock	D	C	B	$74.61
BLLNBillionToOne, Inc. Class A Common Stock	F	F	D	$93.24
CELCCelcuity Inc. Common Stock	—	—	C	$88.44
GRALGRAIL, Inc. Common Stock	D	A	B	$80.00
VCYTVeracyte, Inc.	D	A	C	$43.34
CDNACareDx, Inc.	D	B	A	$49.79
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.07
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.81
FRNMFreenome, Inc. Common stock	—	F	A	$14.79
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	C	$11.51
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$33.50
YDESYD Bio Limited Ordinary Shares	—	—	C	$4.80
BDSXBiodesix, Inc. Common Stock	D	B	A	$26.83
XGNExagen Inc. Common Stock	D	B	C	$7.39
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$10.19
SERASera Prognostics, Inc. Class A Common Stock	D	D	D	$2.07
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.72
ADVBAdvanced Biomed Inc. Common Stock	A	—	A	$9.70
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	F	$2.40
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	C	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.42

About Fulgent Genetics, Inc. Common Stock

Fulgent Genetics is a genetic testing company providing physicians with diagnostic laboratory services and clinical interpretation to guide patient treatment. The company's core laboratory services segment, which generates the majority of revenue, offers technical testing and professional interpretation by licensed physicians. The company also operates a therapeutic development business focused on developing cancer drug candidates, with operations primarily in the United States and select international markets.